A Patient with Active Hepatitis B Presents for Dental Extraction

Affiliations


Abstract

Goals of the dental management of patients with active hepatitis B is to stabilize the patient until the active liver infection subsides and to defer all dental treatments until recovery. If treatment cannot be deferred during the active stage of the disease, consultation with the patient's physician is necessary to obtain information to avoid excessive bleeding, infection, or adverse drug reactions. Dental treatments of such patients should be carried out in an isolated operation room with adherence to the standard precautions to prevent cross-infection. An effective vaccine against hepatitis B is available; all health care workers should be fully vaccinated.

Keywords: Bleeding; Drugs; Hepatitis B; Infections; Management; Odontology.


Similar articles

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.PMID: 12710832

Patient with Chronic Liver Disease Was Referred for Evaluation of Oral Infection and Facial Swelling and Needs Multiple Dental Extractions.

AlMuzaini AA.Dent Clin North Am. 2023 Jul;67(3):557-559. doi: 10.1016/j.cden.2023.02.044. Epub 2023 Mar 25.PMID: 37244740 Review.

Hepatitis B prevalence and infection control among dental health care workers in a community in South Korea.

Song KB, Choi KS, Lang WP, Jacobson JJ.J Public Health Dent. 1999 Winter;59(1):39-43. doi: 10.1111/j.1752-7325.1999.tb03233.x.PMID: 11396043

Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses.

Michelin A, Henderson DK.Clin Liver Dis. 2010 Feb;14(1):119-36; ix-x. doi: 10.1016/j.cld.2009.11.005.PMID: 20123445 Review.

[HCV or HBV infection self-disclosure to dentists].

Nagao Y, Kawaguchi T, Ide T, Sata M.Kansenshogaku Zasshi. 2008 May;82(3):213-9. doi: 10.11150/kansenshogakuzasshi1970.82.213.PMID: 18546851 Japanese.


KMEL References